Astria Therapeutics, Inc. (ATXS)
USD 4.69
(-8.93%)
USD 4.69
(-8.93%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -175.36 Million USD | -795.35% |
| 2022 | -19.58 Million USD | 77.26% |
| 2021 | -86.14 Million USD | -260.67% |
| 2020 | -23.88 Million USD | -212.37% |
| 2019 | -7.64 Million USD | 50.01% |
| 2018 | -15.29 Million USD | -10.11% |
| 2017 | -13.89 Million USD | 22.29% |
| 2016 | -17.87 Million USD | 66.8% |
| 2015 | -53.83 Million USD | -442.67% |
| 2014 | -9.92 Million USD | 67.45% |
| 2013 | -30.47 Million USD | -560702.36% |
| 2012 | -5434.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -81.58 Million USD | 52.66% |
| 2024 Q1 | -172 Million USD | 1.91% |
| 2023 Q2 | -133.31 Million USD | 33.84% |
| 2023 Q3 | -119.31 Million USD | 10.5% |
| 2023 FY | -175.36 Million USD | -795.35% |
| 2023 Q1 | -201.5 Million USD | -928.83% |
| 2023 Q4 | -175.36 Million USD | -46.97% |
| 2022 Q2 | -28.6 Million USD | 38.49% |
| 2022 Q1 | -46.5 Million USD | 46.02% |
| 2022 Q4 | -19.58 Million USD | 56.37% |
| 2022 Q3 | -44.89 Million USD | -56.94% |
| 2022 FY | -19.58 Million USD | 77.26% |
| 2021 FY | -86.14 Million USD | -260.67% |
| 2021 Q2 | -138.8 Million USD | 4.95% |
| 2021 Q4 | -86.14 Million USD | 34.36% |
| 2021 Q3 | -131.23 Million USD | 5.45% |
| 2021 Q1 | -146.03 Million USD | -511.45% |
| 2020 Q1 | -11.59 Million USD | -51.58% |
| 2020 FY | -23.88 Million USD | -212.37% |
| 2020 Q4 | -23.88 Million USD | 53.76% |
| 2020 Q3 | -51.64 Million USD | -2.23% |
| 2020 Q2 | -50.52 Million USD | -335.91% |
| 2019 Q2 | -8.34 Million USD | 17.03% |
| 2019 Q3 | -16.83 Million USD | -101.65% |
| 2019 FY | -7.64 Million USD | 50.01% |
| 2019 Q4 | -7.64 Million USD | 54.59% |
| 2019 Q1 | -10.06 Million USD | 34.2% |
| 2018 Q4 | -15.29 Million USD | 23.05% |
| 2018 Q3 | -19.87 Million USD | 59.52% |
| 2018 Q2 | -49.1 Million USD | -219.39% |
| 2018 Q1 | -15.37 Million USD | -10.68% |
| 2018 FY | -15.29 Million USD | -10.11% |
| 2017 Q1 | -26.87 Million USD | -50.37% |
| 2017 FY | -13.89 Million USD | 22.29% |
| 2017 Q2 | -25.26 Million USD | 6.02% |
| 2017 Q3 | -18.41 Million USD | 27.09% |
| 2017 Q4 | -13.89 Million USD | 24.58% |
| 2016 Q3 | -19.94 Million USD | -17.57% |
| 2016 Q4 | -17.87 Million USD | 10.37% |
| 2016 Q2 | -16.96 Million USD | -7.96% |
| 2016 Q1 | -15.71 Million USD | 70.82% |
| 2016 FY | -17.87 Million USD | 66.8% |
| 2015 Q1 | -14.64 Million USD | -47.65% |
| 2015 Q2 | -71.85 Million USD | -390.54% |
| 2015 FY | -53.83 Million USD | -442.67% |
| 2015 Q4 | -53.83 Million USD | 14.51% |
| 2015 Q3 | -62.96 Million USD | 12.36% |
| 2014 Q4 | -9.92 Million USD | 9.41% |
| 2014 FY | -9.92 Million USD | 67.45% |
| 2014 Q1 | 30.47 Million USD | 200.0% |
| 2014 Q3 | -10.95 Million USD | 0.0% |
| 2013 FY | -30.47 Million USD | -560702.36% |
| 2013 Q4 | -30.47 Million USD | 0.0% |
| 2012 FY | -5434.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -213.486% |
| Alkermes plc | -166.73 Million USD | -5.173% |
| Agenus Inc. | 274.13 Million USD | 163.97% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 109.378% |
| Aptorum Group Limited | 1.35 Million USD | 13022.48% |
| Ardelyx, Inc. | 34.51 Million USD | 608.125% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4197.29% |
| Bicycle Therapeutics plc | -481.46 Million USD | 63.577% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 584.927% |
| ChromaDex Corporation | -24.04 Million USD | -629.225% |
| Chimerix, Inc. | -25.51 Million USD | -587.244% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2616.677% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -640.651% |
| CRISPR Therapeutics AG | -150.84 Million USD | -16.254% |
| Precision BioSciences, Inc. | -85.41 Million USD | -105.32% |
| Dyadic International, Inc. | -6.37 Million USD | -2649.471% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1000.634% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2387.854% |
| Lantern Pharma Inc. | -21.7 Million USD | -708.007% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -58.647% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1952.679% |
| Incyte Corporation | -3.17 Billion USD | 94.477% |
| IO Biotech, Inc. | -140.69 Million USD | -24.638% |
| Jaguar Health, Inc. | 29.39 Million USD | 696.659% |
| Novavax, Inc. | -298.29 Million USD | 41.211% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3385.816% |
| Opthea Limited | 28.15 Million USD | 722.798% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -944.517% |
| ContextLogic Inc. | -232 Million USD | 24.412% |
| MiMedx Group, Inc. | -33.9 Million USD | -417.283% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1820.098% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -7468.492% |
| NextCure, Inc. | -6.47 Million USD | -2607.488% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -247.249% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2649.083% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1541.751% |
| Vaxcyte, Inc. | -368.22 Million USD | 52.376% |
| PDS Biotechnology Corporation | -32.7 Million USD | -436.135% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1114.955% |
| Pharming Group N.V. | 109.8 Million USD | 259.706% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -908.071% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -0.076% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -846.897% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -846.897% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2369.915% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2892.56% |
| Acelyrin, Inc. | -216.9 Million USD | 19.151% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -3025.769% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -10071.926% |
| Summit Therapeutics Inc. | 34.67 Million USD | 605.751% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2477.745% |
| Senti Biosciences, Inc. | 1.74 Million USD | 10178.391% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 5.007% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -126.419% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2792.841% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 175870.029% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 28024.204% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -49.825% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -4.239% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 258.171% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2208.636% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -35.821% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2643.499% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 27.644% |
| Immix Biopharma, Inc. | -17.5 Million USD | -901.52% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 44.628% |
| MEI Pharma, Inc. | -3.7 Million USD | -4633.171% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1501.679% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 208.422% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 730.965% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2387.854% |
| Precigen, Inc. | -481 Thousand USD | -36358.212% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1345.395% |
| AlloVir, Inc. | -62.69 Million USD | -179.723% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -215.323% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 384.377% |
| ImmuCell Corporation | 10.99 Million USD | 1695.587% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -13.765% |
| Onconetix, Inc. | 5.33 Million USD | 3389.245% |
| PureTech Health plc | -167.19 Million USD | -4.885% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -475.719% |
| Elevation Oncology, Inc. | -19.11 Million USD | -817.272% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -3472.296% |
| Seer, Inc. | -4.24 Million USD | -4035.943% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -629.559% |
| Innoviva, Inc. | 255.56 Million USD | 168.619% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -213.912% |
| ESSA Pharma Inc. | -33.62 Million USD | -421.582% |
| GlycoMimetics, Inc. | -40.98 Million USD | -327.88% |
| GT Biopharma, Inc. | -1.02 Million USD | -17075.71% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -158.714% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 386.276% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -30.792% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1165.618% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -507.384% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -232682.011% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -468.22% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2039.928% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -5504.442% |
| Soligenix, Inc. | -4.95 Million USD | -3441.564% |
| Century Therapeutics, Inc. | 847 Thousand USD | 20804.132% |
| Kura Oncology, Inc. | -20.11 Million USD | -771.677% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -328.49% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1988.164% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 9726.419% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -5385.267% |
| Autolus Therapeutics plc | -186.59 Million USD | 6.021% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -255.679% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 36.415% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 611.743% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 206.69% |
| GRI Bio, Inc. | -1.79 Million USD | -9675.028% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1852.166% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -427.3% |
| IGM Biosciences, Inc. | -72.6 Million USD | -141.528% |
| INmune Bio, Inc. | -25.41 Million USD | -590.111% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 216.173% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -246.165% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -979.205% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -5978.631% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 561.302% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -325.796% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 649.989% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 146.399% |
| Verastem, Inc. | -37.27 Million USD | -370.422% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1832.812% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -238.136% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1058.665% |
| Histogen Inc. | -7.48 Million USD | -2242.247% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -711.614% |
| Surrozen, Inc. | -32.66 Million USD | -436.872% |
| Organovo Holdings, Inc. | -1.5 Million USD | -11536.629% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4071.869% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1024.905% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 6803.517% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4319.538% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1992.362% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -303.674% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1103.03% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 44.643% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -24186.624% |
| Apollomics, Inc. | -27.39 Million USD | -540.131% |
| Amarin Corporation plc | -191.04 Million USD | 8.206% |
| Mesoblast Limited | 55.96 Million USD | 413.357% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1102.441% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -593.358% |
| Synaptogenix, Inc. | -28.66 Million USD | -511.845% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -18635.47% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 459.854% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -20241.751% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2313.461% |
| Exelixis, Inc. | -73.05 Million USD | -140.06% |
| Better Therapeutics, Inc. | -860 Thousand USD | -20291.163% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -630.288% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 27.347% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 23924.494% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2257.634% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 14084.37% |
| Gritstone bio, Inc. | 39.49 Million USD | 544.072% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -108.516% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -6562.412% |
| Avid Bioservices, Inc. | 169.72 Million USD | 203.321% |
| Insmed Incorporated | 721.62 Million USD | 124.301% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1818.326% |
| MediWound Ltd. | -5.32 Million USD | -3195.077% |
| OmniAb, Inc. | 9.2 Million USD | 2005.509% |
| Alector, Inc. | -35.63 Million USD | -392.084% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 303.98% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -3458.523% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1424.602% |
| Zai Lab Limited | -775 Million USD | 77.372% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 151.494% |
| Aura Biosciences, Inc. | -21.52 Million USD | -714.699% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -112.614% |
| Immunic, Inc. | -45.34 Million USD | -286.775% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 9.239% |
| Veracyte, Inc. | -203.82 Million USD | 13.963% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 127.474% |
| FibroGen, Inc. | 56.76 Million USD | 408.919% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2069.276% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -6103.004% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -8370.267% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 103.82% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -5148.848% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -5.664% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1081.771% |
| Galecto, Inc. | -21.21 Million USD | -726.565% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -637.288% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 111.174% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -616.59% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1423.977% |
| XBiotech Inc. | -200.02 Million USD | 12.328% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -108.516% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3972.88% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -397.303% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -127.102% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3181.427% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -2.904% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -89.841% |
| Vaxxinity, Inc. | 10.13 Million USD | 1830.794% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 123.818% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1528.634% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -165.88% |
| NexImmune, Inc. | -3.13 Million USD | -5496.17% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -4979.079% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1060.471% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -547.1% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1853.687% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -140669.817% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -332.229% |
| Ainos, Inc. | 4.07 Million USD | 4400.321% |
| Pluri Inc. | 22.82 Million USD | 868.163% |
| Prothena Corporation plc | -608.34 Million USD | 71.174% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -47.667% |
| Celularity Inc. | 65.19 Million USD | 369.004% |
| Rallybio Corporation | -24.1 Million USD | -627.591% |
| Cue Biopharma, Inc. | -33.81 Million USD | -418.537% |
| MeiraGTx Holdings plc | -40.3 Million USD | -335.125% |
| Omeros Corporation | 331.17 Million USD | 152.952% |
| Humacyte, Inc. | -22.48 Million USD | -679.881% |
| Immunocore Holdings plc | -358.59 Million USD | 51.097% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -613.587% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -467.503% |
| Blueprint Medicines Corporation | 702.83 Million USD | 124.951% |
| CalciMedica, Inc. | -5.53 Million USD | -3071.139% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 6.83% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1616.898% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -338.005% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -427.363% |
| Pulmatrix, Inc. | -10.41 Million USD | -1583.441% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2833.98% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -359.766% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -57.415% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -192.546% |
| Cytokinetics, Incorporated | 642.37 Million USD | 127.299% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2911.575% |
| Nutriband Inc. | -251.65 Thousand USD | -69583.736% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -413.978% |
| Vor Biopharma Inc. | 4.3 Million USD | 4178.233% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.095% |
| Evogene Ltd. | -19.63 Million USD | -793.165% |
| ProKidney Corp. | -56.23 Million USD | -211.836% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -260.298% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1798.457% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 112.858% |
| CorMedix Inc. | -43.05 Million USD | -307.326% |
| BioLineRx Ltd. | 7.33 Million USD | 2490.458% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -538.5% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 480.012% |
| Atai Life Sciences N.V. | -28.55 Million USD | -514.063% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 7961.991% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -668.601% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1088.802% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -133.588% |
| MediciNova, Inc. | -50.78 Million USD | -245.317% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -122.529% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -779468.793% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2617.731% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 12.239% |
| Biomea Fusion, Inc. | -166.57 Million USD | -5.279% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 2.018% |
| Mereo BioPharma Group plc | -51.46 Million USD | -240.718% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -84.897% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 40.303% |
| Absci Corporation | -72.59 Million USD | -141.555% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3940.648% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 25.198% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -86.14% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -83.251% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -348.811% |
| Allakos Inc. | -24.97 Million USD | -602.158% |
| Imunon, Inc. | -4.21 Million USD | -4061.608% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1089.554% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -29.516% |
| BioAtla, Inc. | -109.01 Million USD | -60.868% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 23924.494% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -18575.612% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1565.519% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -727.072% |
| XOMA Corporation | -29 Million USD | -504.703% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -958.961% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1845.031% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2254.195% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -40.701% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 15.757% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -114.436% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -89.045% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -20310.529% |
| Akari Therapeutics, Plc | -3.84 Million USD | -4460.832% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 10905.662% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 112.699% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -14659.602% |
| UroGen Pharma Ltd. | 4.39 Million USD | 4093.714% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 254.532% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 243789.725% |
| Orgenesis Inc. | 21.78 Million USD | 905.013% |
| Entera Bio Ltd. | -10.62 Million USD | -1549.864% |
| GH Research PLC | -78.07 Million USD | -124.604% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -686.809% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -557.804% |
| Xencor, Inc. | 29.64 Million USD | 691.567% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -8802.575% |
| Replimune Group, Inc. | 1.41 Million USD | 12519.547% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -71504.031% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -38.719% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -14659.602% |
| Portage Biotech Inc. | -4.98 Million USD | -3420.659% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -779468.793% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -165.213% |
| OncoCyte Corporation | -6.56 Million USD | -2572.01% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 19641.059% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -3749.38% |
| Purple Biotech Ltd. | -14.13 Million USD | -1140.373% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -638.188% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2579.358% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -950.577% |
| HilleVax, Inc. | -165.48 Million USD | -5.97% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -6809.535% |
| Tharimmune, Inc. | -10.93 Million USD | -1503.643% |
| Genprex, Inc. | -6.73 Million USD | -2502.755% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 52.451% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -98.241% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -12417.059% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -5186.912% |
| OKYO Pharma Limited | -826.84 Thousand USD | -21108.735% |
| Savara Inc. | 153 Thousand USD | 114716.993% |
| Curis, Inc. | -23.88 Million USD | -634.14% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3299.904% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -22498.104% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2724.807% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 14898.65% |
| BeiGene, Ltd. | -2.25 Billion USD | 92.217% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1521.275% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 71.167% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 5.508% |
| Erasca, Inc. | -37.21 Million USD | -371.206% |
| bluebird bio, Inc. | 108.57 Million USD | 261.52% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -13516.349% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 146.301% |
| DBV Technologies S.A. | -126.98 Million USD | -38.097% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -13516.349% |
| Moderna, Inc. | -2.9 Billion USD | 93.968% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1594.011% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1513.581% |
| Molecular Templates, Inc. | 707 Thousand USD | 24903.96% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -459.0% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 150.594% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -113.697% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -91.174% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -443.394% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -410.135% |
| MacroGenics, Inc. | -66.98 Million USD | -161.796% |
| RenovoRx, Inc. | -1.17 Million USD | -14850.043% |
| Adicet Bio, Inc. | -138.78 Million USD | -26.355% |
| Prime Medicine, Inc. | -27.94 Million USD | -527.622% |
| Aditxt, Inc. | 18.12 Million USD | 1067.745% |
| Adagene Inc. | -87.62 Million USD | -100.125% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4109.988% |
| Quantum-Si incorporated | -118.55 Million USD | -47.915% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 587.055% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2246.262% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -261.508% |
| SciSparc Ltd. | -2.06 Million USD | -8392.203% |
| Vericel Corporation | 1.27 Million USD | 13832.498% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1362.378% |
| Minerva Neurosciences, Inc. | 41 Million USD | 527.673% |
| Generation Bio Co. | 31.44 Million USD | 657.632% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -467.099% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 250.407% |
| Invivyd, Inc. | -198.47 Million USD | 11.645% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -94.266% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -7213.878% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -147.724% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2469.436% |
| 2seventy bio, Inc. | 181.71 Million USD | 196.505% |
| ADMA Biologics, Inc. | 90.06 Million USD | 294.706% |
| Clene Inc. | 3.34 Million USD | 5350.419% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1830.747% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -715.229% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2617.731% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 49.04% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -574.485% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 198.704% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4185.986% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 3605.878% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3266.558% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -34.581% |
| Evaxion Biotech A/S | 5.28 Million USD | 3416.988% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -55.785% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -33.587% |
| Trevena, Inc. | 2.25 Million USD | 7866.342% |
| Surrozen, Inc. | -32.66 Million USD | -436.872% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -240.447% |
| Cingulate Inc. | 3.08 Million USD | 5788.681% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -5870.855% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2540.017% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1787.415% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -121.076% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -33.405% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -66.156% |
| Clearmind Medicine Inc. | -3.94 Million USD | -4347.886% |
| Kronos Bio, Inc. | -36.05 Million USD | -386.393% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1963.79% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 12126.662% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -223.216% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1316.42% |
| ImmunityBio, Inc. | 618.22 Million USD | 128.366% |
| Korro Bio, Inc. | -132.94 Million USD | -31.909% |
| Kineta, Inc. | -4.54 Million USD | -3761.793% |
| BioVie Inc. | -17.73 Million USD | -888.95% |
| Codexis, Inc. | -43.27 Million USD | -305.269% |
| Celularity Inc. | 65.19 Million USD | 369.004% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -5433.733% |
| Celcuity Inc. | 6.78 Million USD | 2685.152% |
| Virax Biolabs Group Limited | -3.36 Million USD | -5111.498% |
| Cibus, Inc. | -8.07 Million USD | -2070.884% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -4046.701% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 3937.287% |
| IN8bio, Inc. | -16.38 Million USD | -970.01% |
| Kodiak Sciences Inc. | -103.87 Million USD | -68.822% |
| Annexon, Inc. | -193.75 Million USD | 9.492% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 487222.222% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -902.137% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -4891.859% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 116.634% |
| Eyenovia, Inc. | 1.25 Million USD | 14032.13% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 751.79% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5307.462% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -427.458% |
| Arcellx, Inc. | -296.95 Million USD | 40.947% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -799.026% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -197.858% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -746.066% |
| Moolec Science SA | 117.61 Thousand USD | 149198.762% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -356.689% |
| Geron Corporation | 14.76 Million USD | 1288.022% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -362.482% |
| Royalty Pharma plc | 5.65 Billion USD | 103.099% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -24.001% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2408.991% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3169.972% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -24.609% |
| Humacyte, Inc. | -22.48 Million USD | -679.881% |
| Structure Therapeutics Inc. | -124.33 Million USD | -41.037% |
| 89bio, Inc. | -289.05 Million USD | 39.332% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -594.731% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -9735.334% |
| Genelux Corporation | -6.89 Million USD | -2441.876% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -464.616% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 309.768% |
| Notable Labs, Ltd. | -9.77 Million USD | -1693.822% |
| Liquidia Corporation | -80.17 Million USD | -118.724% |
| Mustang Bio, Inc. | -3.73 Million USD | -4593.897% |
| Immunovant, Inc. | -635.22 Million USD | 72.393% |
| Quantum-Si incorporated | -118.55 Million USD | -47.915% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -898.429% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -4132.778% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2284.677% |
| Acasti Pharma Inc. | -23 Million USD | -662.286% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -5107.962% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -979.205% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -27.315% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -5527.202% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -688.791% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -844.391% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -3.595% |
| PepGen Inc. | -60.67 Million USD | -189.046% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -663.249% |
| United Therapeutics Corporation | -507.7 Million USD | 65.459% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -816.888% |
| Solid Biosciences Inc. | -47.75 Million USD | -267.254% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -20241.751% |
| Immuneering Corporation | -54.94 Million USD | -219.175% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4071.869% |
| Silo Pharma, Inc. | -3.52 Million USD | -4875.842% |
| Belite Bio, Inc | -87.27 Million USD | -100.942% |
| XOMA Corporation | -29 Million USD | -504.703% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -148.05% |
| Bionomics Limited | 227 Million USD | 177.249% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -50.809% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6823.174% |
| uniQure N.V. | -102.95 Million USD | -70.337% |
| Cassava Sciences, Inc. | -121.13 Million USD | -44.766% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4109.988% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 528.229% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1366.132% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -5567.507% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 165537.736% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5307.462% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2069.276% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2264.671% |
| Altimmune, Inc. | -134.48 Million USD | -30.395% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 188.539% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6823.174% |
| Compugen Ltd. | -12.9 Million USD | -1258.989% |
| Peak Bio, Inc. | 10.34 Million USD | 1795.951% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -61866.078% |
| Benitec Biopharma Inc. | -50.58 Million USD | -246.692% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -68.073% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 992.665% |
| Zura Bio Limited | -99.8 Million USD | -75.705% |
| PolyPid Ltd. | 6.17 Million USD | 2942.204% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 336.595% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 992.665% |
| Instil Bio, Inc. | 75.35 Million USD | 332.708% |
| argenx SE | -2.02 Billion USD | 91.356% |
| Immunome, Inc. | -97.02 Million USD | -80.734% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -679.569% |
| Verona Pharma plc | -220.44 Million USD | 20.449% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -144.434% |
| Shattuck Labs, Inc. | -121.42 Million USD | -44.423% |
| CervoMed Inc. | -7.79 Million USD | -2150.32% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 5.464% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -3910.153% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -33.114% |
| Moolec Science SA | 117.61 Thousand USD | 149198.762% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -7564.588% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1203.031% |
| AnaptysBio, Inc. | -18.15 Million USD | -866.14% |
| Design Therapeutics, Inc. | -18.15 Million USD | -866.193% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -149.164% |
| NeurAxis, Inc. | 145.7 Thousand USD | 120459.643% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1661.289% |
| Lumos Pharma, Inc. | -28.49 Million USD | -515.463% |
| Achilles Therapeutics plc | -126.92 Million USD | -38.165% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -144.434% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -26643.324% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -744.158% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 12126.662% |
| Nutriband Inc. | -251.65 Thousand USD | -69583.736% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1231.44% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2257.043% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 151.548% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 838.841% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 60.81% |
| Palisade Bio, Inc. | -12.06 Million USD | -1353.735% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -24.982% |
| Beam Therapeutics Inc. | -262.72 Million USD | 33.251% |
| Neurogene Inc. | -131.95 Million USD | -32.897% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 903.832% |
| AEON Biopharma, Inc. | -4.88 Million USD | -3493.525% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 53.508% |
| Sesen Bio, Inc. | -112.55 Million USD | -55.806% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -75.61% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -7369.313% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -349.352% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -110.567% |
| Athira Pharma, Inc. | -88.99 Million USD | -97.04% |
| Vaccinex, Inc. | -1.28 Million USD | -13515.217% |
| HCW Biologics Inc. | 2.85 Million USD | 6238.743% |
| XOMA Corporation | -29 Million USD | -504.703% |
| Nektar Therapeutics | 210.24 Million USD | 183.411% |
| Arvinas, Inc. | -313.8 Million USD | 44.116% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 10905.662% |
| Merus N.V. | -192.88 Million USD | 9.083% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 392.346% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2427.587% |
| Rezolute, Inc. | -68.16 Million USD | -157.253% |
| Clene Inc. | 3.34 Million USD | 5350.419% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1229.825% |
| BeyondSpring Inc. | -13.75 Million USD | -1174.911% |
| Synlogic, Inc. | -6.68 Million USD | -2523.246% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 15564.198% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1974.086% |
| Peak Bio, Inc. | 10.34 Million USD | 1795.951% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -112.769% |
| Krystal Biotech, Inc. | -350.23 Million USD | 49.929% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 241.28% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -3.768% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -5454.514% |
| MannKind Corporation | 143.89 Million USD | 221.866% |
| Ikena Oncology, Inc. | -109.15 Million USD | -60.654% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2216.259% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -429.801% |
| Gossamer Bio, Inc. | 180.35 Million USD | 197.233% |
| CohBar, Inc. | -5.93 Million USD | -2856.87% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -489.498% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3940.648% |
| Legend Biotech Corporation | -949.39 Million USD | 81.529% |
| Mural Oncology plc | -255.84 Million USD | 31.456% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 644.355% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -3622.72% |
| Disc Medicine, Inc. | -358.28 Million USD | 51.054% |
| Champions Oncology, Inc. | 4.81 Million USD | 3744.306% |
| REGENXBIO Inc. | 54.76 Million USD | 420.194% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -65113.624% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -16.117% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1845.893% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -117.349% |
| Vaxart, Inc. | -8.24 Million USD | -2027.946% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -249.47% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -37.902% |
| Cellectis S.A. | -43.85 Million USD | -299.872% |
| Longeveron Inc. | -2.9 Million USD | -5930.399% |
| Repare Therapeutics Inc. | -107.85 Million USD | -62.588% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 118.109% |
| Inozyme Pharma, Inc. | 12 Million USD | 1560.88% |
| Revolution Medicines, Inc. | -608.2 Million USD | 71.167% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -14157.236% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 33.854% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -16.853% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1020.752% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -23597.838% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.166% |
| Denali Therapeutics Inc. | -74.86 Million USD | -134.24% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1362.378% |
| Veru Inc. | 4.77 Million USD | 3768.727% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1459.346% |
| Cingulate Inc. | 3.08 Million USD | 5788.681% |
| Passage Bio, Inc. | 4.58 Million USD | 3924.733% |
| Context Therapeutics Inc. | -14.44 Million USD | -1113.606% |
| Exicure, Inc. | 5.84 Million USD | 3098.188% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 23.879% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -343.174% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1217.609% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -198.132% |
| Nuvalent, Inc. | -335.38 Million USD | 47.713% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 10211.276% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -135.445% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1872.598% |
| OmniAb, Inc. | 9.2 Million USD | 2005.509% |
| Anew Medical, Inc. | 1.43 Million USD | 12342.114% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1170.484% |
| Lipocine Inc. | -4.75 Million USD | -3588.308% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -59.671% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1251.362% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -246.165% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 804.499% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2509.195% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -166.401% |
| Ocugen, Inc. | -32.52 Million USD | -439.233% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -104.924% |
| Q32 Bio Inc. | -37.94 Million USD | -362.117% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -27824.204% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1196.208% |
| Equillium, Inc. | -22.39 Million USD | -683.155% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -585.873% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -437.485% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -70635.534% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 230.828% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 5583.552% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 53492.847% |
| Dominari Holdings Inc. | 195 Thousand USD | 90030.256% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3229.542% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1866.626% |
| Bio-Techne Corporation | 267.74 Million USD | 165.496% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -981.893% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -48.495% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1986.921% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1286.167% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 28.458% |
| Nkarta, Inc. | 57.29 Million USD | 406.051% |
| BioCardia, Inc. | 212 Thousand USD | 82818.868% |
| Iterum Therapeutics plc | 13.43 Million USD | 1404.986% |